Status:
COMPLETED
A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age
Lead Sponsor:
Novartis
Collaborating Sponsors:
Novartis Vaccines
Conditions:
Influenza
Eligibility:
All Genders
6-35 years
Phase:
PHASE1
Brief Summary
This study will evaluate the safety and immunogenicity of different combinations of influenza vaccine in healthy young children.
Eligibility Criteria
Inclusion
- Children of 6 month to \<36 month of age in good health as determined by medical history, physical assessment and clinical judgement of the investigator.
Exclusion
- History of serious disease. History of serious reaction following administration of vaccine or hypersensitivity to vaccine components. Known or suspected impairment/alteration of immune function.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
410 Patients enrolled
Trial Details
Trial ID
NCT00848887
Start Date
October 1 2008
End Date
May 1 2009
Last Update
January 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCL St. Luc - Pharmacy
Brussels, Belgium, 1200